AWS, Deloitte, Microsoft and NVIDIA bring the latest in AI technology, coordination, and compute to the alliance and back with initial funding

New Orizon Fund to provide financial and operational support to OREF grant recipients seeking to commercialize innovative, patient-focused healthcare solutions.

Following favorable FDA feedback for the treatment of liver disease, the company is preparing further pre-IND meetings with the FDA for the treatment of atherosclerosis and familial hypercholesterolemia

Physicians and healthcare providers can attend the instructor course of TAI Chi now available at the conference. Dr AJ Farshchian held classes for Physicians.

With a $500,000 grant from the GI Research Foundation to Dr. Osman Ahmed, UChicago Medicine will be one of only four hospitals using a new technique to noninvasively treat liver cancer.

Now patients, caregivers and healthcare professionals have an easy and effective way to search for and match with gastric cancer clinical trials.

With $3.5 million in funding from the GI Research Foundation, a team at the MD Anderson Cancer Center explores a one-two punch to combat BRAF-mutated colorectal cancer and its “dismal prognosis.”

A University of Chicago team is exploring how a series of cooking classes, focused on nutrition and making better food choices, impact participants’ gastrointestinal microbiomes and overall health. Supported in part by the GI Research Foundation, they are seeing quick improvements to participants’ gut health that may motivate people to keep eating better.

A University of Chicago team identified a special type of stem cell that heals damaged bowel tissue in mice, a discovery that may have direct application to humans with inflammatory bowel disease. These early findings, made possible with seed funding from the GI Research Foundation, resulted in a recent five-year, $2.5 million grant from the National Institutes of Health to study those cells in humans.

Beginning in the second quarter of 2023, NIT will provide Actinium-225 in millicurie quantities, marking a significant step forward in cancer treatment

The $50,000 Vilcek Prizes for Creative Promise recognize rising immigrant scientists living and working in the United States whose work represents a significant contribution to their field.

The $50,000 Vilcek Prizes for Creative Promise recognize rising immigrant scientists living and working in the United States whose work represents a significant contribution to their field.

The Vilcek Prizes for Creative Promise recognize rising immigrant scientists living and working in the United States whose work represents a significant contribution to their field.

Prizes awarded in honor of immigrant leaders in the arts and sciences, including musicians Du Yun and Angélique Kidjo, and scientist Alejandro Sánchez Alvarado

New technology provides non-prescription, non-addictive, mess-free alternative to relieve congestion and runny nose

Accuracy options for the CPC6050 Modular Pressure Controller have been enhanced to offer more variety and better accuracy specifications. With these improvements, in addition to 0.01% FS and 0.01% IS-50, users can achieve premium accuracies of 0.008% FS, 0.008% IS-50, and 0.008% IS-33 with the CPR6050.

Federated learning enables collaboration without sharing data, so privacy is always protected

First Treatments for Patients with Rare Conditions Proven to Work

The BRAIN Foundation Opens Synchrony 2020, the annual symposium on translational research in autism; From Bench to BioPharma, with a day of presentations from leading researchers in animal models of autism.

Synchrony is the first and only international symposium on translational research in autism that brings together academia, biotech, pharmaceutical companies, and venture partners from around the world with the mission to improve the health and quality of life of people with autism. Synchrony is the annual symposium of The BRAIN Foundation, supported this year by UC Davis MIND Institute and Caltech.

Synchrony is the first and only international symposium on translational research in autism, that brings together academia, biotech, pharmaceutical companies and venture partners from around the world. The theme of the Symposium is: From Bench to Biopharma. CharmHealth and its community of physicians are sponsoring this virtual event to bring together researchers and physicians in the cutting-edge of academia and industry to address comorbidities and disabling medical symptoms in ASD.

CūtisCare is committed to supporting research and education in wound care and hyperbaric medicine to further its reputation as a quality-first provider of wound care services and to support therapeutic advancements that improve patient care and healing outcomes

New eISF Standard Reference Model Promises to Strengthen Collaboration Among Stakeholders in Clinical Trial Life cycle.

The research will focus on nanotechnology-based CBD products for the treatment of psoriasis and other diseases

AASCP is hosting an FDA Panel and many distinguished physicians this weekend at their annual Scientific Congress. All physicians practicing stem cell treatments should not miss this event on Nov. 1-3, 2019.

American Academy of Stem Cell Physicians joins the Alliance for Cell Therapy Now to discuss industry safety standards

The AASCP has set up safety guidelines for Physicians who use regenerative therapies in their practice.

Challenging Board certifications with the AASCP are a big success

The conference, held Aug. 2-4, 2019 in Miami, features hands-on training and is holding qualifying exam for board certification.

Small nonprofit run by parent volunteers seeking to make a big impact and save their children

Groundbreaking Cystic Fibrosis Foundation Joins Forces with Eesho in Race for a Cure During Signature NYC Event

Application of Real-World Patient Data Radically Enhances Volunteer Commitment

With generous support for research funding, The Ehlers-Danlos Society sponsors International Symposium in Ghent, Belgium, to accelerate collaborative global research into EDS, HSD, their related symptoms and associated conditions.

Florence announces over 2,000 clinical trial sites are now using Florence eBinders to accelerate studies with eRegulatory and eSource.

Master the Waves of Life